Search

everythinglearnresearchcommunity

for

Search:↓

1,25-dihydroxyvitamin D3 helps melanocyte precursors from hair follicles grow and produce melanin, aiding vitiligo treatment understanding.

A sphingolipid from human placenta may help treat vitiligo by activating melanocyte stem cells.

The treatment was effective for advanced non-Hodgkin's lymphomas.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

The study found markers indicating that cells responsible for hair color are differentiating in specific areas of the hair follicle.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

The research showed how melanocytes develop, move, and respond to UV light, and their stem cells' role in hair color and skin cancer risk.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Topical eyedrops may cause eyelash whitening and skin lightening around the eyes.

Some chemicals can permanently or temporarily remove color from skin and hair, which can be distressing and is not well-regulated in cosmetics.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

A rare pigmented skin tumor called melanotrichoblastoma was diagnosed in a 51-year-old woman.

BMI1 is essential for preventing hair greying and maintaining hair color.

TPA is about 50 times more effective at promoting tumors than MZ.

Noncultured epidermal cell transplantation is effective for repigmenting stable vitiligo.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

DHEA inhibits growth in both mouse and human melanoma cells but works differently in each.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Nilotinib can cause skin issues like red bumps and hair loss.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.